NDP

protein-coding

norrin cystine knot growth factor NDP, the group of Receptor ligands

Gene summary

This gene encodes a secreted protein with a cystein-knot motif that activates the Wnt/beta-catenin pathway. The protein forms disulfide-linked oligomers in the extracellular matrix. Mutations in this gene result in Norrie disease and X-linked exudative vitreoretinopathy. [provided by RefSeq, Feb 2009]

Previous symbols:
  • EVR2

MANE transcript

NM_000266.4

Inheritance

XL, AD

ClinVar variants

P:93U:63B:34

Top phenotype

Norrie disease; Exudative vitreoretinopathy, 2, X-linked

gnomAD constraint

pLI —, LoF o/e 0

Max pathogenic AF

—

Genomic locus

chrX:43,948,776-43,973,395

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~24.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

exudative vitreoretinopathy 2, X-linkedSTRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010588

Submitter: Labcorp Genetics (formerly Invitae)

Norrie diseaseSTRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010691

Submitter: Labcorp Genetics (formerly Invitae)

Norrie diseaseDEFINITIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010691

Submitter: G2P

exudative vitreoretinopathy 2, X-linkedDEFINITIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010588

Submitter: G2P

Norrie diseaseDEFINITIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010691

Submitter: Ambry Genetics

exudative vitreoretinopathySUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0019516

Submitter: Orphanet

Norrie diseaseSUPPORTIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010691

Submitter: Orphanet

persistent hyperplastic primary vitreousSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0019631

Submitter: Orphanet

Norrie diseaseSTRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010691

Submitter: PanelApp Australia

Norrie diseaseDEFINITIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010691

Submitter: ClinGen

The association between the NDP gene and Norrie disease (ND) is well-characterized, with over 100 unique variants described in HGMD, including nonsense, missense, splice, and deletion variants reported in dozens of publications. Familial segregation data is readily available; only a subset are included in this curation. Experimental evidence includes several mouse models of disease and protein interaction studies highlighting NDP's role in FZD4 interaction and Wnt signaling. NOTE: In terms of X-linked intellectual disability, ND is incompletely penetrant. The main phenotype associated with ND is abnormal vascular development within the eye, and only ~50% of patients with ND exhibit intellectual disability.

Clinical Genomic Database (CGD)

Norrie disease; Exudative vitreoretinopathy, 2, X-linkedXL

Manifestation: Ophthalmologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 95062; 1303235; 1307245; 1642288; 8252044; 8457509; 8110678; 7662640; 7814011; 7795608; 7627181; 8990009; 17325173; 17334993; 20301506; 20491809; 20679667; 21179243; 21960066; 22563645; 22674248Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to NDP variants in ClinVar

18 Conditions Cataloged
not providedTotal: 157
Atrophia bulborum hereditariaTotal: 39
not specifiedTotal: 26
Retinal dystrophyTotal: 14
NDP-related disordersTotal: 14
NDP-related disorderTotal: 11
Exudative vitreoretinopathy 2, X-linkedTotal: 10
Inborn genetic diseasesTotal: 8

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_000266.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
27
clinvar
28
missense
21
clinvar
33
clinvar
60
clinvar
7
clinvar
121
nonsense
10
clinvar
6
clinvar
1
clinvar
17
start loss
1
clinvar
1
clinvar
2
frameshift
9
clinvar
9
clinvar
18
splice donor/acceptor (+/-2bp)
2
clinvar
1
clinvar
1
clinvar
4
Total435063340190

Highest pathogenic variant AF is 9.332032e-7

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 9 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_000266.4RefSeqNP_000257.12MANE Select
ENST00000642620.1EnsemblENSP00000495972.12MANE Select
ENST00000647044.1EnsemblENSP00000495811.12Standard
ENST00000647044.2EnsemblENSP00000495811.12Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
ndpDanio rerio

Structure: ocular blood vessel

Quality: decreased area

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • GPCR signaling-G alpha q
  • GPCR signaling-cholera toxin
  • GPCR signaling-pertussis toxin
  • GPCR signaling-G alpha s Epac and ERK
  • GPCR signaling-G alpha s PKA and ERK

Biological Process

  • placenta development
  • vacuole organization
  • signal transduction
  • cell-cell signaling
  • nervous system development

Molecular Function

  • frizzled binding
  • cytokine activity
  • protein binding
  • growth factor activity
  • protein homodimerization activity

Cellular Component

  • extracellular space
  • cell surface
  • collagen-containing extracellular matrix

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000378062
Coding exons
2
Length
24729
Individuals with no LoFs
0
Homozygous LoFs
0
Heterozygous LoFs
0
Defined
0
p
0.00
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.9693150.40.6160.00000330855
Missense (PolyPhen)522.8810.21853392
Synonymous-0.7572621.51.210.00000144272
Loss of Function1.7103.390.002.12e-755

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)00.0absent
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. Plays a central role in retinal vascularization by acting as a ligand for FZD4 that signals via stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. Acts in concert with TSPAN12 to activate FZD4 independently of the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1). May be involved in a pathway that regulates neural cell differentiation and proliferation. Possible role in neuroectodermal cell-cell interaction.;
Disease
DISEASE: Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]: A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. {ECO:0000269|PubMed:16163268, ECO:0000269|PubMed:16970763, ECO:0000269|PubMed:17296899, ECO:0000269|PubMed:17325173, ECO:0000269|PubMed:8252044, ECO:0000269|PubMed:8946107, ECO:0000269|PubMed:9143917}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.479

Intolerance Scores

RVIS EVS
0.28
RVIS percentile EVS
70.87

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.234

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.